Highlights of the advances in basic immunology in 2011

Cellular and Molecular Immunology

Volumn 9, Issue 3, 2012, Pages 197-207

  Liu, Juan ^a   Liu, Shuxun ^a   Cao, Xuetao ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

ILC; innate immunity; TFR cells; Th17 cells; TLR

Indexed keywords

BETA INTERFERON; CD40 ANTIGEN; DNA POLYMERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RETINOIC ACID INDUCIBLE PROTEIN I; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; CELL DIFFERENTIATION; CELL FUNCTION; CYTOSOL; HELPER CELL; IMMUNE SYSTEM; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOREACTIVITY; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOID CELL; MEMORY T LYMPHOCYTE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TRANSPORT; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

ADAPTIVE IMMUNITY; ALLERGY AND IMMUNOLOGY; ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MICRORNAS; RESEARCH; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TOLL-LIKE RECEPTORS;

EID: 84860852558     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.12     Document Type: Review

References (175)

1. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343: 338-344.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801. (Pubitemid 43261452)
3. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-251. (Pubitemid 24046687)
4. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216. (Pubitemid 34293424)
5. Barbalat R, Ewald SE, Mouchess ML, Barton GM. Nucleic acid recognition by the innate immune system. Annu Rev Immunol 2011; 29: 185-214.
6. Barton GM. Viral recognition by Toll-like receptors. Semin Immunol 2007; 19: 33-40. (Pubitemid 46498754)
7. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, MiyagishiMet al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5: 730-737. (Pubitemid 39023305)
8. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, MiyagishiM, Taira K et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005; 175: 2851-2858. (Pubitemid 41170502)
9. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009; 10: 1073-1080.
10. Pichlmair A, Lassnig C, Eberle CA, Gó rna MW, Baumann CL, Burkard TR et al. IFIT1 is an antiviral protein that recognizes 59-triphosphate RNA. Nat Immunol 2011; 12: 624-630.
11. Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F et al. RIG-Imediated antiviral responses to single-stranded RNA bearing 59-phosphates. Science 2006; 314: 997-1001. (Pubitemid 44749946)
12. Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H et al. 59-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314: 994-997.
13. Ablasser A, Hornung V. Where, in antiviral defense, does IFIT1 fit? Nat Immunol 2011; 12: 588-590.
14. Zhang Z, Kim T, Bao M, Facchinetti V, Jung SY, Ghaffari AA et al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011; 34: 866-878.
15. Zhang Z, Yuan B, Lu N, Facchinetti V, Liu YJ. DHX9 pairs with IPS-1 to sense doublestranded RNA in myeloid dendritic cells. J Immunol 2011; 187: 4501-4508.
16. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. Structural insights into RNA recognition by RIG-I. Cell 2011; 147: 409-422.
17. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011; 147: 423-435.
18. Jiang F, Ramanathan A, Miller MT, Tang GQ, GaleM, Patel SS et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011; 479: 423-427.
19. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J et al. 29-O methylation of the viral mRNAcap evades host restrictionby IFIT familymembers. Nature 2010; 468: 452-456.
20. ZüstR, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J et al.Ribose 29-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 2011; 12: 137-143.
21. García-Sastre A. 2 methylate or not 2 methylate: viral evasion of the type I interferon response. Nat Immunol 2011; 12: 114-115.
22. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007; 448: 501-505. (Pubitemid 47123520)
23. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458: 509-513.
24. Hornung V, Ablasser A, Charrel-DennisM, Bauernfeind F, Horvath G, Caffrey DR et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458: 514-518.
25. Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10: 266-272.
26. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138: 576-591.
27. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-Idependent sensing of poly(dA:dT) through the induction of an RNA polymerase IIItranscribed RNA intermediate. Nat Immunol 2009; 10: 1065-1072.
28. Cao X. New DNA-sensing pathway feeds RIG-I with RNA. Nat Immunol 2009; 10: 1049-1051.
29. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010; 11: 997-1004.
30. Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011; 12: 959-965.
31. Zhang X, Brann TW, Zhou M, Yang J, Oguariri RM, Lidie KBet al. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol 2011; 186: 4541-4545.
32. Barber GN. STING-dependent signaling. Nat Immunol 2011; 12: 929-930.
33. Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 2010; 11: 487-494.
34. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511. (Pubitemid 38931765)
35. Wang C, Chen T, Zhang J, Yang M, Li N, Xu X et al. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat Immunol 2009; 10: 744-752.
36. Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol 2011; 12: 416-424.
37. Hassan GS, Mourad W. An unexpected role for MHC class II. Nat Immunol 2011; 12: 375-376.
38. Tun-Kyi A, Finn G, Greenwood A, Nowak M, Lee TH, Asara JM et al. Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat Immunol 2011; 12: 733-741.
39. Saitoh T, Satoh T, Yamamoto N, Uematsu S, Takeuchi O, Kawai T et al. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 2011; 34: 352-363.
40. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446-458. (Pubitemid 40835033)
41. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000; 289: 2350-2354.
42. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAKM is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191-202. (Pubitemid 34876547)
43. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002; 17: 677-687. (Pubitemid 35351512)
44. WaldD,Qin J, Zhao Z, Qian Y, NaramuraM, Tian L et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4: 920-927. (Pubitemid 37098664)
45. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, O'Neill LA et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004; 5: 373-379. (Pubitemid 38500085)
46. Kawagoe T, Takeuchi O, Takabatake Y, Kato H, Isaka Y, Tsujimura T et al. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 2009; 10: 965-972.
47. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively regulates TLRtriggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 2010; 11: 734-742.
48. Yuk JM, Shin DM, Lee HM, Kim JJ, Kim SW, Jin HS et al. The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors. Nat Immunol 2011; 12: 742-751.
49. Beyaert R. SHP works a double shift to control TLR signaling. Nat Immunol 2011; 12: 725-727.
50. Kufer TA, Sansonetti PJ. NLR functions beyond pathogen recognition. Nat Immunol 2011; 12: 121-128.
51. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q et al. NLRX1 negatively regulates TLR-induced NF-kB signaling by targeting TRAF6 and IKK. Immunity 2011; 34: 843-853.
52. Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, Scull MA et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kB signaling pathways. Immunity 2011; 34: 854-865.
53. Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M, Ciaccio MF et al. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 2011; 147: 853-867.
54. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity 2011; 34: 680-692.
55. Ramos HJ, Gale M Jr. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr Opin Virol 2011; 1: 167-176.
56. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, Kashigi F et al. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol 2011; 12: 37-44.
57. McWhirter SM, Tenoever BR, Maniatis T. Connecting mitochondria and innate immunity. Cell 2005; 122: 645-647. (Pubitemid 41242626)
58. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446: 916-920. (Pubitemid 46633167)
59. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455: 674-678.
60. Okabe Y, Sano T, Nagata S. Regulation of the innate immune response by threoninephosphatase of Eyes absent. Nature 2009; 460: 520-524.
61. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. MAVS forms function al prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011; 146: 448-461.
62. Chen H, Sun H, You F, Sun W, Zhou X, Chen L et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 2011; 147: 436-446.
63. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011; 12: 21-27.
64. Gascoyne DM, Long E, Veiga-Fernandes H, de Boer J, Williams O, Seddon B et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 2009; 10: 1118-1124.
65. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR. An essential function for the nuclear receptor RORct in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5: 64-73. (Pubitemid 38081470)
66. Possot C, Schmutz S, Chea S, Boucontet L, Louise A, Cumano A et al.Notch signaling is necessary for adult, but not fetal, development of RORct1 innate lymphoid cells. Nat Immunol 2011; 12: 949-958.
67. Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya Met al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 2012; 13: 144-151.
68. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453: 65-71. (Pubitemid 351630328)
69. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH)2 cells. Nat Immunol 2009; 10: 864-871.
70. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457: 722-725.
71. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C et al. Natural Aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011; 334: 1561-1565.
72. Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, Grigorieva EF et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011; 147: 629-640.
73. Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Bérard M, Kleinschek M et al. RORct1 innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011; 12: 320-326.
74. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12: 1045-1054.
75. Wills-Karp M, Finkelman FD. Innate lymphoid cells wield a double-edged sword. Nat Immunol 2011; 12: 1025-1027.
76. Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B et al. Human IL- 25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12: 1055-1062.
77. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12: 631-638.
78. Bordon Y. Asthma and allergy: influenza virus and an innate form of asthma. Nat Rev Immunol 2011; 11: 443.
79. Cormier SA, Kolls JK. Innate IL-13 in virus-induced asthma? Nat Immunol 2011; 12: 587-588.
80. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357. (Pubitemid 16136806)
81. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173. (Pubitemid 19138011)
82. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485-517.
83. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-787. (Pubitemid 351707693)
84. O'Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD41 T cells. Science 2010; 327: 1098-1102.
85. Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci USA 2004; 101: 1993-1998. (Pubitemid 38229003)
86. Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A et al. Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 2004; 279: 26983-26990. (Pubitemid 38812534)
87. Tanaka S, Motomura Y, Suzuki Y, Yagi R, Inoue H, Miyatake S et al. The enhancer HS2 critically regulates GATA-3-mediated Il4 transcription in TH2 cells. Nat Immunol 2011; 12: 77-85.
88. van Stry M, Bix M. Explaining discordant coordination. Nat Immunol 2011; 12: 16-17.
89. Leavy O. T cells: shaping Il4 gene expression. Nat Rev Immunol 2011; 11: 3.
90. Kool M, Willart MA, van Nimwegen M, Bergen I, Pouliot P, Virchow JC et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011; 34: 527-540.
91. Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, Akira S et al. Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 2011; 34: 514-526.
92. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453: 1122-1126. (Pubitemid 351871731)
93. Pelka K, Latz E. Getting closer to the dirty little secret. Immunity 2011; 34: 455-458.
94. Bordon Y. Allergy: crystal clear culprit. Nat Rev Immunol 2011; 11: 304.
95. Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, Moser B et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-51 TH2 cells. Nat Immunol 2011; 12: 167-177.
96. Debes GF, Diehl MC. CCL8 and skin T cells-an allergic attraction. Nat Immunol 2011; 12: 111-112.
97. Li Z, Zhang Y, Liu Z, Wu X, Zheng Y, Tao Z et al. ECM1 controls TH2 cell egress from lymph nodes through re-expression of S1P1. Nat Immunol 2011; 12: 178-185.
98. Bordon Y. Lymphocyte migration: travel agents for two. Nat Rev Immunol 2011; 11: 77.
99. Martinez GJ, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory TH17 cells. Ann NY Acad Sci 2008; 1143: 188-211.
100. IvanovII, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007; 19: 409-417. (Pubitemid 351274050)
101. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 2011; 146: 772-784.
102. Nutsch K, Hsieh C. When T cells run out of breath: the HIF-1a story. Cell 2011; 146: 673-674.
103. Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN et al. T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORct. Nat Immunol 2011; 12: 96-104.
104. Yang XP, Ghoreschi K, Steward-Tharp SM, Rodriguez-Canales J, Zhu J, Grainger JR et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol 2011; 12: 247-254.
105. Cao W, Yang Y, Wang Z, Liu A, Fang L, Wu F et al. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 2011; 35: 273-284.
106. Awasthi A, Kuchroo VK. Value added: neural progenitor cells suppress inflammation and autoimmunity. Immunity 2011; 35: 156-157.
107. Solt LA, Kumar N, Nuhant P, Wang Y, Lauer JL, Liu J et al. Suppression of TH17 differentiation and autoimmunity by a synthetic RORligand. Nature 2011; 472: 491-494.
108. Jetten AM. Immunology: a helping hand against autoimmunity. Nature 2011; 472: 421-422.
109. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL- 23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240. (Pubitemid 40189432)
110. Codarri L, Gyülvészi G, Tosevski V, Hesske L, Fontana A, Magnenat L et al. RORct drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011; 12: 560-567.
111. El-Behi M, Ciric B, Dai H, Yan Y, CullimoreM, Safavi F et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GMCSF. Nat Immunol 2011; 12: 568-575.
112. McGeachy MJ. GM-CSF: the secret weapon in the TH17 arsenal. Nat Immunol 2011; 12: 521-522.
113. Xu S, Cao X. Interleukin-17 and its expanding biological functions. Cell Mol Immunol 2010; 7: 164-174.
114. Song X, Zhu S, Shi P, Liu Y, Shi Y, Levin SD et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol 2011; 12: 1151-1158.
115. Ramirez-Carrozzi V, Sambandam A, Luis E, Lin Z, Jeet S, Lesch J et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 2011; 12: 1159-1166.
116. Swamy M, Hayday A. Provocative exhibits at the Seventeen Gallery. Nat Immunol 2011; 12: 1131-1133.
117. Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 2011; 35: 611-621.
118. Martinez GJ, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory TH17 cells. Ann NY Acad Sci 2008; 1143: 188-211.
119. Sakaguchi S. Naturally arising CD41 regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-562. (Pubitemid 38680433)
120. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253-257. (Pubitemid 37323210)
121. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD41CD251 regulatory T cells. Nat Immunol 2003; 4: 330-336. (Pubitemid 36432314)
122. Cretney E, Xin A, Shi W, Minnich M, Masson F, Miasari M et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol 2011; 12: 304-311.
123. Ohkura N, Sakaguchi S. Maturation of effector regulatory T cells. Nat Immunol 2011; 12: 283-284.
124. Maruyama T, Li J, Vaque JP, Konkel JE, Wang W, Zhang B et al. Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3. Nat Immunol 2011; 12: 86-95.
125. Tone M, Greene MI. Cooperative regulatory events and Foxp3 expression. Nat Immunol 2011; 12: 14-16.
126. Wang Y, Su MA, Wan YY. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011; 35: 337-348.
127. Mantel PY, KuipersH, Boyman O, Rhyner C, Ouaked N, Rückert B et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007; 5: e329.
128. Campbell DJ. Regulatory T cells GATA have it. Immunity 2011; 35: 313-315.
129. Beal AM, Ramos-Hernandez N, Riling CR, Nowelsky EA, Oliver PM. TGF-b induces the expression of the adaptor Ndfip1 to silence IL-4 production during iTreg cell differentiation. Nat Immunol 2012; 13: 77-85.
130. Beyer M, Thabet Y, Müller RU, Sadlon T, Classen S, Lahl K et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol 2011; 12: 898-907.
131. King C. New insights into the differentiation and function of T follicular helper cells. Nat Rev Immunol 2009; 9: 757-766.
132. Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS,MaL et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008; 29: 138-149.
133. King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 2008; 26: 741-766. (Pubitemid 351600391)
134. Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL et al. The transcriptional repressor Bcl- 6 directs T follicular helper cell lineage commitment. Immunity 2009; 31: 457-468.
135. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD et al. Bcl6 mediates the development of T follicular helper cells. Science 2009; 325: 1001-1005.
136. Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009; 325: 1006-1010.
137. Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, Sharpe AH et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol 2009; 10: 167-175.
138. Pelletier N, McHeyzer-Williams LJ, Wong KA, Urich E, Fazilleau N, McHeyzer- Williams MG. Plasma cells negatively regulate the follicular helper T cell program. Nat Immunol 2010; 11: 1110-1118.
139. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G et al. Human blood CXCR51CD41 T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34: 108-121.
140. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009; 10: 595-602.
141. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 2009; 458: 351-356.
142. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A et al. CD41 regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326: 986-991.
143. Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF et al. Foxp31 follicular regulatory T cells control the germinal center response. Nat Med 2011; 17: 975-982.
144. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011; 17: 983-988.
145. Wollenberg I, Agua-Doce A, Hernandez A, Almeida C, Oliveira VG, Faro J et al. Regulation of the germinal center reaction by foxp31 follicular regulatory T cells. J Immunol 2011; 187: 4553-4560.
146. Papatriantafyllou M. Regulatory T cells: pursuing a germinal centre career. Nat Rev Immunol 2011; 11: 572.
147. Campbell DJ, Koch MA. Treg cells cells: patrolling a dangerous neighborhood. Nat Med 2011; 17: 929-930.
148. Yang CY, Best JA, Knell J, Yang E, Sheridan AD, Jesionek AK et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD81 T cell subsets. Nat Immunol 2011; 12: 1221-1229.
149. Ji Y, Pos Z, Rao M, Klebanoff CA, Yu Z, Sukumar M et al. Repression of the DNAbinding inhibitor Id3 by Blimp-1 limits the formation of memory CD81 T cells. Nat Immunol 2011; 12: 1230-2137.
150. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF et al. mTOR regulates memory CD8 T-cell differentiation. Nature 2009; 460: 108-112.
151. Rao RR, Li Q, Odunsi K, Shrikant PA. The mTOR kinase determines effector versus memory CD81 T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 2010; 32: 67-78.
152. Li Q, Rao RR, Araki K, Pollizzi K, Odunsi K, Powell JD et al. A central role for mTOR kinase in homeostatic proliferation induced CD81 T cell memory and tumor immunity. Immunity 2011; 34: 541-553.
153. Liu G, Yang K, Burns S, Shrestha S, Chi H. The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells. Nat Immunol 2010; 11: 1047-1056.
154. Lee K, Gudapati P, Dragovic S, Spencer C, Joyce S, Killeen N et al. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 2010; 32: 743-753.
155. Powell JD, Delgoffe GM. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010; 33: 301-311.
156. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, XiaoB et al. ThemTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009; 30: 832-844.
157. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, HortonMR et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 2011; 12: 295-303.
158. Michalek RD, Gerriets VA, JacobsSR, Macintyre AN, MacIver NJ, Mason EF et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD41 T cell subsets. J Immunol 2011; 186: 3299-3303.
159. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
160. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007; 104: 1604-1609. (Pubitemid 46214637)
161. Bezman NA, Cedars E, Steiner DF, Blelloch R, Hesslein DG, Lanier LL. Distinct requirements of microRNAs in NK cell activation, survival, and function. J Immunol 2010; 185: 3835-3846.
162. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486. (Pubitemid 44267285)
163. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-161. (Pubitemid 46507589)
164. Ebert PJ, Jiang S, Xie J, Li QJ, Davis MM. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol 2009; 10: 1162-1169.
165. Stittrich AB, Haftmann C, Sgouroudis E, Kühl AA, Hegazy AN, Panse I et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010; 11: 1057-1062.
166. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T et al. Function of miR- 146a in controlling Treg cells cell-mediated regulation of Th1 responses. Cell 2010; 142: 914-929.
167. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA et al. MicroRNA-155 promotes autoimmune inflammation by enhancing nflammatory T cell development. Immunity 2010; 33: 607-619.
168. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S et al.MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009; 10: 1252-1259.
169. Leavy O. Immune regulation: (micro)Control of IFNc. Nat Rev Immunol 2011; 11: 573.
170. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-c. Nat Immunol 2011; 12: 861-869.
171. Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, Allen CD et al. MicroRNA-29 regulates T-box transcription factors and interferon-c production in helper T cells. Immunity 2011; 35: 169-181.
172. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, Bonnal RJ et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD41 T cells by themicroRNA miR-125b. Nat Immunol 2011; 12: 796-803.
173. Oertli M, Engler DB, Kohler E, KochM, Meyer TF,Müller A.MicroRNA-155 is essential for the T cell-mediated control of helicobacter pylori infection and for the induction of chronic gastritis and colitis. J Immunol 2011; 187: 3578-3586.
174. Blüml S, Bonelli M, Niederreiter B, Puchner A, Mayr G, Hayer S et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 2011; 63: 1281-1288.
175. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 9: 839-845. (Pubitemid 352038302)